ABCC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.616100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.974800E-01
Normal-vs-Stage2
1.429850E-02
Normal-vs-Stage3
1.046390E-01
Normal-vs-Stage4
3.679000E-01
Stage1-vs-Stage2
3.596800E-01
Stage1-vs-Stage3
2.811000E-01
Stage1-vs-Stage4
5.734400E-01
Stage2-vs-Stage3
4.727600E-01
Stage2-vs-Stage4
2.807800E-01
Stage3-vs-Stage4
1.925150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.149610E-01
Normal-vs-AfricanAmerican
4.491800E-02
Normal-vs-Asian
8.062000E-02
Caucasian-vs-AfricanAmerican
3.004000E-01
Caucasian-vs-Asian
4.671000E-01
AfricanAmerican-vs-Asian
6.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.614480E-02
Normal-vs-Female
2.497800E-01
Male-vs-Female
1.338560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.067800E-01
Normal-vs-Age(41-60Yrs)
1.537980E-01
Normal-vs-Age(61-80Yrs)
3.272300E-02
Normal-vs-Age(81-100Yrs)
7.483600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.156800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.742200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.820600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.276760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.270400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.948800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.227800E-02
Normal-vs-Daily Drinker
1.757230E-01
Normal-vs-Weekly Drinker
3.011700E-02
Normal-vs-Occasional Drinker
3.574000E-01
Normal-vs-Social Drinker
4.775000E-01
Non Drinker-vs-Daily Drinker
3.578000E-01
Non Drinker-vs-Weekly Drinker
8.765000E-01
Non Drinker-vs-Occasional Drinker
2.660400E-01
Non Drinker-vs-Social Drinker
2.083400E-01
Daily Drinker-vs-Weekly Drinker
4.734400E-01
Daily Drinker-vs-Occasional Drinker
7.498200E-01
Daily Drinker-vs-Social Drinker
5.985800E-01
Weekly Drinker-vs-Occasional Drinker
3.469400E-01
Weekly Drinker-vs-Social Drinker
3.097800E-01
Occasional Drinker-vs-Social Drinker
8.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.085200E-01
Normal-vs-Grade 2
7.336300E-02
Normal-vs-Grade 3
1.118810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.360200E-01
Grade 1-vs-Grade 3
5.153400E-01
Grade 1-vs-Grade 4
4.085200E-01
Grade 2-vs-Grade 3
4.041000E-01
Grade 2-vs-Grade 4
7.336300E-02
Grade 3-vs-Grade 4
1.118810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.976610E-01
Normal-vs-NonDiabetic
2.172800E-01
Diabetic-vs-NonDiabetic
2.315200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.471200E-01
Normal-vs-NoPancreatitis
1.556160E-01
Pancreatitis-vs-NoPancreatitis
3.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.227400E-01
Normal-vs-N1
1.088310E-02
N0-vs-N1
2.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.361700E-02
Normal-vs-TP53-NonMutant
3.032400E-01
TP53-Mutant-vs-TP53-NonMutant
2.722000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
